Concepts (228)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiosurgery | 23 | 2017 | 355 | 2.120 |
Why?
|
| Brain Neoplasms | 18 | 2019 | 637 | 1.300 |
Why?
|
| Gamma Rays | 3 | 2015 | 25 | 0.570 |
Why?
|
| Radiometry | 4 | 2015 | 52 | 0.520 |
Why?
|
| Radiation Oncology | 2 | 2013 | 14 | 0.500 |
Why?
|
| Meningioma | 4 | 2014 | 59 | 0.460 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2014 | 1224 | 0.400 |
Why?
|
| Societies, Scientific | 1 | 2013 | 16 | 0.400 |
Why?
|
| Molecular Imaging | 1 | 2013 | 18 | 0.400 |
Why?
|
| Meningeal Neoplasms | 3 | 2014 | 49 | 0.380 |
Why?
|
| Brain | 5 | 2015 | 965 | 0.370 |
Why?
|
| Cranial Irradiation | 5 | 2017 | 94 | 0.370 |
Why?
|
| Burns | 1 | 2012 | 102 | 0.340 |
Why?
|
| Models, Animal | 1 | 2011 | 188 | 0.330 |
Why?
|
| Skin | 1 | 2012 | 212 | 0.320 |
Why?
|
| Salvage Therapy | 6 | 2015 | 135 | 0.310 |
Why?
|
| Whole-Body Irradiation | 5 | 2015 | 58 | 0.300 |
Why?
|
| Radiation Injuries | 4 | 2017 | 85 | 0.240 |
Why?
|
| Nomograms | 3 | 2015 | 35 | 0.230 |
Why?
|
| Neoplasm Recurrence, Local | 4 | 2015 | 381 | 0.230 |
Why?
|
| Male | 28 | 2017 | 19441 | 0.220 |
Why?
|
| Carmustine | 1 | 2015 | 11 | 0.220 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2015 | 45 | 0.220 |
Why?
|
| Trigeminal Neuralgia | 2 | 2015 | 33 | 0.220 |
Why?
|
| Middle Aged | 21 | 2017 | 11851 | 0.220 |
Why?
|
| Humans | 30 | 2019 | 32282 | 0.210 |
Why?
|
| Treatment Outcome | 13 | 2017 | 3416 | 0.210 |
Why?
|
| Female | 27 | 2019 | 19945 | 0.210 |
Why?
|
| Retrospective Studies | 13 | 2015 | 3626 | 0.210 |
Why?
|
| Aged | 18 | 2017 | 10263 | 0.200 |
Why?
|
| Animals | 16 | 2019 | 8199 | 0.190 |
Why?
|
| Adult | 17 | 2017 | 9259 | 0.190 |
Why?
|
| Radiation Injuries, Experimental | 2 | 2015 | 37 | 0.190 |
Why?
|
| Breast Neoplasms | 4 | 2019 | 762 | 0.190 |
Why?
|
| Radiotherapy Dosage | 7 | 2017 | 107 | 0.180 |
Why?
|
| Lung Neoplasms | 3 | 2015 | 423 | 0.160 |
Why?
|
| Treatment Failure | 6 | 2015 | 165 | 0.160 |
Why?
|
| Cognition Disorders | 2 | 2015 | 349 | 0.160 |
Why?
|
| Magnetic Field Therapy | 1 | 2019 | 15 | 0.150 |
Why?
|
| Macaca mulatta | 3 | 2017 | 340 | 0.150 |
Why?
|
| Calcium Channels, T-Type | 1 | 2019 | 28 | 0.150 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 1083 | 0.140 |
Why?
|
| Aged, 80 and over | 9 | 2014 | 3900 | 0.140 |
Why?
|
| Follow-Up Studies | 8 | 2015 | 2240 | 0.130 |
Why?
|
| Aging | 2 | 2014 | 942 | 0.130 |
Why?
|
| Calcium | 1 | 2019 | 339 | 0.130 |
Why?
|
| Radiation Dosage | 3 | 2012 | 91 | 0.130 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2017 | 34 | 0.120 |
Why?
|
| Cerebrovascular Disorders | 1 | 2017 | 51 | 0.120 |
Why?
|
| Brain Injuries | 1 | 2017 | 75 | 0.120 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2016 | 20 | 0.120 |
Why?
|
| Phantoms, Imaging | 2 | 2015 | 70 | 0.120 |
Why?
|
| Epilepsy | 1 | 2017 | 79 | 0.120 |
Why?
|
| Calibration | 2 | 2015 | 24 | 0.120 |
Why?
|
| Facial Pain | 2 | 2014 | 21 | 0.120 |
Why?
|
| Pain Measurement | 2 | 2014 | 341 | 0.110 |
Why?
|
| Central Nervous System Diseases | 1 | 2015 | 17 | 0.110 |
Why?
|
| Melanoma | 2 | 2015 | 166 | 0.110 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 2 | 2012 | 34 | 0.110 |
Why?
|
| Brain Edema | 1 | 2014 | 16 | 0.110 |
Why?
|
| X-Rays | 2 | 2011 | 7 | 0.110 |
Why?
|
| Growth Hormone | 2 | 2013 | 15 | 0.110 |
Why?
|
| Brain Stem Neoplasms | 1 | 2014 | 4 | 0.100 |
Why?
|
| Dog Diseases | 1 | 2013 | 12 | 0.100 |
Why?
|
| Survival Rate | 5 | 2017 | 893 | 0.100 |
Why?
|
| Vein of Galen Malformations | 1 | 2013 | 3 | 0.100 |
Why?
|
| Carcinoma, Small Cell | 1 | 2013 | 21 | 0.100 |
Why?
|
| Cerebral Veins | 1 | 2013 | 11 | 0.100 |
Why?
|
| Health Physics | 1 | 2013 | 4 | 0.100 |
Why?
|
| Radiobiology | 1 | 2013 | 5 | 0.100 |
Why?
|
| Brain Death | 1 | 2013 | 23 | 0.100 |
Why?
|
| Kidney Neoplasms | 2 | 2012 | 200 | 0.090 |
Why?
|
| Sensitivity and Specificity | 2 | 2011 | 556 | 0.090 |
Why?
|
| Radio Waves | 1 | 2012 | 6 | 0.090 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2012 | 27 | 0.090 |
Why?
|
| Temperature | 1 | 2012 | 58 | 0.090 |
Why?
|
| Neurilemmoma | 1 | 2012 | 17 | 0.090 |
Why?
|
| Cell Proliferation | 2 | 2019 | 603 | 0.090 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2012 | 17 | 0.090 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2013 | 157 | 0.090 |
Why?
|
| Cesium Radioisotopes | 1 | 2011 | 4 | 0.090 |
Why?
|
| Reproducibility of Results | 2 | 2011 | 757 | 0.090 |
Why?
|
| Proportional Hazards Models | 4 | 2015 | 773 | 0.090 |
Why?
|
| Disease-Free Survival | 3 | 2013 | 324 | 0.090 |
Why?
|
| Collagen Diseases | 1 | 2011 | 5 | 0.090 |
Why?
|
| Survival Analysis | 4 | 2013 | 477 | 0.080 |
Why?
|
| Nanotubes, Carbon | 1 | 2011 | 19 | 0.080 |
Why?
|
| Adenocarcinoma | 1 | 2013 | 298 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 1 | 2013 | 395 | 0.080 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2011 | 36 | 0.080 |
Why?
|
| Macaca fascicularis | 2 | 2015 | 542 | 0.080 |
Why?
|
| Vascular Diseases | 1 | 2011 | 66 | 0.080 |
Why?
|
| Time Factors | 5 | 2014 | 2205 | 0.080 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2012 | 113 | 0.080 |
Why?
|
| Iron | 1 | 2011 | 94 | 0.080 |
Why?
|
| Cognition | 1 | 2014 | 547 | 0.080 |
Why?
|
| Multiple Sclerosis | 1 | 2011 | 62 | 0.080 |
Why?
|
| Etidronic Acid | 1 | 2009 | 3 | 0.080 |
Why?
|
| Mice | 5 | 2019 | 2571 | 0.080 |
Why?
|
| Bone Density Conservation Agents | 1 | 2009 | 23 | 0.080 |
Why?
|
| Hippocampus | 1 | 2011 | 216 | 0.070 |
Why?
|
| Dose-Response Relationship, Radiation | 3 | 2015 | 83 | 0.070 |
Why?
|
| Glioblastoma | 1 | 2011 | 159 | 0.070 |
Why?
|
| Tumor Burden | 3 | 2014 | 63 | 0.070 |
Why?
|
| Osteoporosis | 1 | 2009 | 51 | 0.070 |
Why?
|
| Bone and Bones | 1 | 2009 | 91 | 0.070 |
Why?
|
| Radiotherapy | 1 | 2009 | 92 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 478 | 0.070 |
Why?
|
| Hyperthermia, Induced | 1 | 2011 | 236 | 0.070 |
Why?
|
| Osteoclasts | 1 | 2008 | 25 | 0.070 |
Why?
|
| Osteogenesis | 1 | 2008 | 79 | 0.070 |
Why?
|
| Subtraction Technique | 1 | 2008 | 9 | 0.070 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2007 | 19 | 0.070 |
Why?
|
| Pattern Recognition, Automated | 1 | 2008 | 36 | 0.070 |
Why?
|
| Rats | 4 | 2014 | 1895 | 0.070 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2008 | 65 | 0.070 |
Why?
|
| Artificial Intelligence | 1 | 2008 | 63 | 0.060 |
Why?
|
| Cell Line, Tumor | 3 | 2019 | 729 | 0.060 |
Why?
|
| Ovary | 1 | 2007 | 66 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 595 | 0.060 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2008 | 103 | 0.060 |
Why?
|
| Child | 3 | 2014 | 2435 | 0.060 |
Why?
|
| Rats, Inbred F344 | 3 | 2013 | 151 | 0.060 |
Why?
|
| Young Adult | 4 | 2014 | 2649 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2009 | 907 | 0.060 |
Why?
|
| Liver Neoplasms | 1 | 2008 | 164 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2011 | 1425 | 0.060 |
Why?
|
| Gene Expression Profiling | 2 | 2019 | 315 | 0.060 |
Why?
|
| Algorithms | 1 | 2008 | 536 | 0.050 |
Why?
|
| Prostatic Neoplasms | 1 | 2009 | 489 | 0.050 |
Why?
|
| Recurrence | 2 | 2015 | 285 | 0.050 |
Why?
|
| Cause of Death | 2 | 2015 | 236 | 0.050 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 555 | 0.050 |
Why?
|
| Stereotaxic Techniques | 2 | 2014 | 23 | 0.050 |
Why?
|
| Radiography | 2 | 2015 | 363 | 0.050 |
Why?
|
| Adolescent | 3 | 2016 | 3519 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 3 | 2010 | 792 | 0.050 |
Why?
|
| Intracranial Hemorrhages | 2 | 2013 | 34 | 0.050 |
Why?
|
| Incidence | 2 | 2015 | 1241 | 0.040 |
Why?
|
| HMGA2 Protein | 1 | 2019 | 10 | 0.040 |
Why?
|
| Electromagnetic Fields | 1 | 2019 | 26 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 1 | 2019 | 65 | 0.040 |
Why?
|
| Neoplastic Stem Cells | 1 | 2019 | 96 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 545 | 0.030 |
Why?
|
| Models, Biological | 1 | 2019 | 408 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2013 | 2316 | 0.030 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2016 | 23 | 0.030 |
Why?
|
| Neuronal Plasticity | 1 | 2017 | 84 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 124 | 0.030 |
Why?
|
| Air | 1 | 2015 | 7 | 0.030 |
Why?
|
| Hypesthesia | 1 | 2015 | 9 | 0.030 |
Why?
|
| United States | 2 | 2015 | 4072 | 0.030 |
Why?
|
| Water | 1 | 2015 | 65 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2015 | 77 | 0.030 |
Why?
|
| Lymphoid Tissue | 1 | 2015 | 11 | 0.030 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2015 | 20 | 0.030 |
Why?
|
| Chemokine CCL2 | 1 | 2015 | 48 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2015 | 97 | 0.030 |
Why?
|
| Spatial Behavior | 1 | 2014 | 11 | 0.030 |
Why?
|
| Reoperation | 1 | 2015 | 252 | 0.030 |
Why?
|
| Ovariectomy | 1 | 2015 | 202 | 0.030 |
Why?
|
| Exploratory Behavior | 1 | 2014 | 33 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2015 | 140 | 0.030 |
Why?
|
| Brain Stem | 1 | 2014 | 22 | 0.030 |
Why?
|
| Perfusion Imaging | 1 | 2013 | 6 | 0.030 |
Why?
|
| Pituitary Gland | 1 | 2013 | 10 | 0.030 |
Why?
|
| Dogs | 1 | 2013 | 126 | 0.020 |
Why?
|
| Macrophages | 1 | 2015 | 207 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2013 | 93 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2015 | 499 | 0.020 |
Why?
|
| History, 18th Century | 1 | 2013 | 2 | 0.020 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2013 | 37 | 0.020 |
Why?
|
| Pain | 1 | 2015 | 304 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 651 | 0.020 |
Why?
|
| History, 21st Century | 1 | 2013 | 62 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2013 | 85 | 0.020 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2014 | 108 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2013 | 191 | 0.020 |
Why?
|
| Organ Size | 1 | 2013 | 221 | 0.020 |
Why?
|
| Embolization, Therapeutic | 1 | 2013 | 81 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2013 | 171 | 0.020 |
Why?
|
| Receptors, Progesterone | 1 | 2012 | 50 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2012 | 104 | 0.020 |
Why?
|
| Karnofsky Performance Status | 1 | 2012 | 12 | 0.020 |
Why?
|
| Receptor, erbB-2 | 1 | 2012 | 63 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2012 | 38 | 0.020 |
Why?
|
| Pain, Postoperative | 1 | 2014 | 199 | 0.020 |
Why?
|
| Facial Paralysis | 1 | 2011 | 6 | 0.020 |
Why?
|
| Hydrocephalus | 1 | 2011 | 11 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2015 | 1840 | 0.020 |
Why?
|
| Ectodysplasins | 1 | 2011 | 2 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2011 | 5 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2011 | 13 | 0.020 |
Why?
|
| Neurogenesis | 1 | 2011 | 17 | 0.020 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2011 | 19 | 0.020 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2011 | 36 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2012 | 104 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2011 | 48 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2012 | 461 | 0.020 |
Why?
|
| Functional Laterality | 1 | 2011 | 62 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2011 | 37 | 0.020 |
Why?
|
| Otitis Media | 1 | 2011 | 24 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2010 | 86 | 0.020 |
Why?
|
| Microglia | 1 | 2011 | 67 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2011 | 285 | 0.020 |
Why?
|
| Contrast Media | 1 | 2011 | 136 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2010 | 24 | 0.020 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2011 | 149 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 471 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2010 | 196 | 0.020 |
Why?
|
| Glioma | 1 | 2011 | 137 | 0.020 |
Why?
|
| Primates | 1 | 2010 | 128 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2013 | 1233 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2010 | 264 | 0.020 |
Why?
|
| Prevalence | 1 | 2012 | 955 | 0.020 |
Why?
|
| Systems Integration | 1 | 2009 | 11 | 0.020 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2009 | 21 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 883 | 0.020 |
Why?
|
| Safety | 1 | 2009 | 65 | 0.020 |
Why?
|
| Artifacts | 1 | 2009 | 45 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2011 | 553 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2011 | 461 | 0.020 |
Why?
|
| Apoptosis | 1 | 2010 | 375 | 0.020 |
Why?
|
| Image Enhancement | 1 | 2008 | 66 | 0.020 |
Why?
|
| Radiographic Image Enhancement | 1 | 2007 | 30 | 0.020 |
Why?
|
| Risk Factors | 1 | 2014 | 3934 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2012 | 823 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2008 | 839 | 0.020 |
Why?
|